EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanodrug‐Engineered Exosomes Achieve a Jointly Dual‐Pathway Inhibition on Cuproptosis

Hanxiao Sun, Yang Zou, Zhengtai Chen, Yan He, Kai Ye, Huan Liu, Lihong Qiu, Yufan Zhang, Yuexue Mai, Xinghong Chen, Zhengwei Mao iD, Wei Wang iD und 1 weitere

Advanced Science · 2025-01 · 12 (4)

DOI: 10.1002/advs.202413408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.12.2024. Verfasst von Hanxiao Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310000, China. Hauptthemen laut MEDLINE: Exosomes, Copper, Wound Healing. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Zhejiang University School of Medicine Affiliated Second Hospital start-up funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, caused by an intracellular overload of copper (Cu) ions and overexpression of ferredoxin 1 (FDX1), is identified for its regulatory role in the skin wound healing process. This study verifies the presence of cuproptosis in skin wound beds and reactive oxygen species‐induced cells model. To address the two pathways leading to cell cuproptosis, a nanodrug‐engineered exosomes is proposed. A Cu‐chelator (Clioquinol, CQ) polydopamine (PDA)‐modified stem cell exosome loaded with siRNA‐FDX1, named EXO siFDX1‐PDA@CQ , is designed to efficiently inhibit the two cuproptosis pathways. The functionalized exosomes are loaded into an injectable hydrogel and applied to treat diabetic wounds in mice and acute skin wounds in pigs. The local and controlled release of EXO siFDX1‐PDA@CQ ensures the retention of the therapeutic agent at wound beds, effectively promoting wound healing. The strategy of engineered exosomes with functional nanoparticles (NPs) proposed in this study offers an efficient and scalable new approach for regulating cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesCopperWound HealingAnimalsMiceSwineNanoparticlesSkinPolymersHumansIndoles

Stichwörter der Autor:innen

FDX1cuproptosisengineered exosomeswound healing

Substanzen

CopperpolydopaminePolymersIndoles

Autor:innen und Institutionen

  • The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310000, China.
  • College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.

ORCID-Profile: Zhengwei Mao, Wei Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Zhejiang University School of Medicine Affiliated Second Hospital start-up funds

Zitieren

APA

Sun, H., Zou, Y., Chen, Z., He, Y., Ye, K., Liu, H., Qiu, L., Zhang, Y., Mai, Y., Chen, X., Mao, Z., Wang, W., & Yi, C. (2025). Nanodrug‐Engineered Exosomes Achieve a Jointly Dual‐Pathway Inhibition on Cuproptosis. Advanced Science, 12(4). https://doi.org/10.1002/advs.202413408

Vancouver

Sun H, Zou Y, Chen Z, He Y, Ye K, Liu H, et al. Nanodrug‐Engineered Exosomes Achieve a Jointly Dual‐Pathway Inhibition on Cuproptosis. Advanced Science. 2025;12(4). doi:10.1002/advs.202413408

BibTeX
@article{Sun2025,
  author = {Sun, Hanxiao and Zou, Yang and Chen, Zhengtai and He, Yan and Ye, Kai and Liu, Huan and Qiu, Lihong and Zhang, Yufan and Mai, Yuexue and Chen, Xinghong and Mao, Zhengwei and Wang, Wei and Yi, Chenggang},
  title = {Nanodrug‐Engineered Exosomes Achieve a Jointly Dual‐Pathway Inhibition on Cuproptosis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {4},
  doi = {10.1002/advs.202413408}
}
Kostenlos starten →